FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Analyst Coverage


Research (commissioned) initiated on 30 November 2020 (see press release here).

SEB’s corporate page on FluoGuide is here.

HC Andersen Capital

Research (commissioned) initiated April 2021. Please visit